Announcements and Notices
VOLUNTARY ANNOUNCEMENT - NATIONAL MEDICAL PRODUCTS ADMINISTRATION GRANTED MARKETING APPROVAL FOR DISITAMAB VEDOTIN FOR INJECTION FOR THE TREATMENT OF HER2-POSITIVE ADVANCED BREAST CANCER WITH LIVER METASTASIS IN CHINA
09
2025.05
